Abstract
A short historical review and pharmacological data indicating the suitability of cycloserine for long-term low-dose prophylaxis of urinary tract infection are presented.
Similar content being viewed by others
References
Bailey, R. R., Roberts, A. P., Gower, P. E., de Wardener, H. E.: Prevention of urinary tract infection with low-dose nitrofurantoin.Lancet, 2, 1112 (1971).
Birnbaum, J.: Rational design of new antibiotic combinations. In: A. G. Bearn (ed.): Antibiotics in the Management of Infections: Outlook for the 1980s. Raven Press, New York 1982, p. 81.
Bondi, A., Kornblum, J. T., Forte, C.: Inhibition of antibacterial activity of cycloserine by alpha-alanine.Proc. Soc. Exp. Biol. Med., 96, 270 (1957).
Brumfitt, W., Cooper, J., Hamilton-Miller, J. M. T.: Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate.J. Urol., 126, 71 (1981).
Bykova, M. A., Storozhev, I. A., Berezina, E. K.: On the pharmacology of D-cycloserine (in Russian).Antibiotiki, 10, 626 (1965).
Cockett, A. T. K., Roberts, A. P., Moore, R. S., Goodwin, W. E.: Selection of antibiotics in acute pyelonephritis based on renal interstitial (lymph) concentration.Br. J. Urol., 40, 564 (1968).
Fairbrother, R. W., Garrett, G.: Treatment of urinary infections with cycloserine.Br. Med. J., 2, 1191 (1960).
Fica, V., Matrescu, Fl., Manole, Gh.: Contributions to the study of the value of cycloserine (Tebemycin) in the treatment of acute attacks of chronic pyelonephritis (in Romanian).Rev. Med. Interna (Bucuresti),27, 291 (1975).
Georgescu, P., Savuleanu, E., Daniello, I.: The rhythm of absorption and elimination of cycloserine as studied with the chromatographic technique.Scand. J. Resp. Dis., Suppl.71, 61 (1970).
Grüneberg, R. N.: Extended treatment of urinary tract infection. In: A. W. Asscher (ed.): Management of Urinary Tract Infections. Medicine Publishing Foundation, Oxford 1980, p. 73.
Herrold, R. D.: Some considerations in the administration of novobiocin and cycloserine.J. Urol., 77, 771 (1957).
Herrold, R. D., Boand, A. V., Kamp, M.: The treatment of stubborn urinary infections with a new antibiotic: cycloserine.Antbiot. Med., 1, 665 (1955).
Herrold, R. D., Karabatsos, N.: Prolonged administration of cycloserine in recurrent urinary infections.J. Urol., 84, 191 (1960).
Hoeprich, P. D.: Effect of DL-alanine on D-cycloserine inhibition of bacteria.Clin. Res., 10, 111 (1962).
Hoeprich, P. D.: Alanine-cycloserine antagonism. II. Significance of phenomenon to therapy with cycloserine.Arch. Intern. Med., 112, 405 (1963).
Hoeprich, P. D.: Alanine-cycloserine antagonism. III. Quantitative aspects and relation to heating of culture media.J. Lab. Clin. Med., 62, 657 (1963).
Holmberg, L., Boman, G., Böttiger, L. E., Eriksson, B., Spross, R., Wessling, A.: Adverse reactions to nitrofurantoin. Analysis of 921 reports.Am. J. Med., 69, 733 (1980).
Hughes, J., Coppridge, W. M., Roberts, L. C.: Cycloserine in chronic urinary infections.J. Urol., 80, 75 (1958).
Janda, J.: Urovalidin Bracco in the treatment of urinary pathway infections in children (in Czech).Česk. Pediatr., 28, 445 (1973).
Kaltenis, P.: Validity of low-dose antibacterial prophylaxis of pyelonephritis in children with vesicoureteral reflux (in Russian). In: Abstracts of the 3rd All-Union Congress of Urologists. Minsk 1974, p. 163.
Landes, R. R., Lyon, E. W., Burch, J. F., Davila, J. M.: Cycloserine in the treatment of acute urinary infections.J. Urol., 83, 490 (1960).
Liwski, R., Koziolova, H., Gietko, E.: Urovalidin treatment of chronic pyelonephritis (in Polish).Pol. Arch. Med. Wewn., 43, 1181 (1969).
Murdoch, J. McC.: Antimicrobials in 1978: a review of current opinion.Curr. Med. Res. Opin., 6, Suppl. 3, 36 (1979).
Murdoch, J. McC., Sleigh, J. D., Frazer, S. C.: Cycloserine in treatment of infection of urinary tract.Br. Med. J., 2, 1055 (1959).
Murray, B. E., Rensimer, E. R., DuPont, H. L.: Emergence of high-level trimethoprim resistance in fecalEscherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole.N. Engl. J. Med., 306, 130 (1982).
Navashin, S. M., Formina, I. P.: Rational Therapy by Antibiotics (in Russian). 4th ed. Medicina, Moscow 1982.
Ormonde, N. W. H., Gray, J. A., Murdoch, J. McC., Wallace, E., Brumfitt, W., Pursell, R., Regan, J. W.: Chronic bacteriuria due toEscherichia coli. I. Assessment of the value of combined short- and long-term treatment with cycloserine, nitrofurantoin, and sulphadimidine.J. Infect. Dis., 120, 82 (1969).
Renzetti, A. D., Wright, K. W., Edling, J. H., Bunn, P.: Clinical, bacteriologic, and pharmacologic observations upon cycloserine.Am. Rev. Tuberc., 74, 128 (1956).
Ronald, A. R., Harding, G. K. M., Mathias, R., Wong, C. K., Muir, P.: Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.Can. Med. Assoc. J., 112, Spec. issue 13, 138 (1975).
Shmelev, N. A., Shabalova, L. N., Kolosovskaya, V. P.: Comparative clinico-electro-encephalographic studies on cycloserine and terizidone tolerance (in Russian).Antibiotiki, 20, 174 (1975).
Shockman, G. D.: Reversal of cycloserine inhibition by D-alanine.Proc. Soc. Exp. Biol. Med., 101, 693 (1959).
Spencer, J. N., Payne, H. G.: Cycloserine. Experimental studies.Antibiot. Chemother., 6, 708 (1956).
Stamey, T. A., Condy, M., Mihara, G.: Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections,N. Engl. J. Med., 296, 780 (1977).
Stamm, W. E.: Prevention of urinary tract infections.Am. J. Med., 76, 5A, 148 (1984).
Stamm, W. E., Counts, G. W., Wagner, K. F., Martin, D., Gregory, D., McKevitt, M., Turck, M., Holmes, K. K.: Antimicrobial prophylaxis of recurrent urinary tract infections.Ann. Intern. Med., 92, 770 (1980).
Utkin, V. V.: Cycloserine in Therapy of Lung Tuberculosis (in Russian). Moscow 1968.
Vaitilavičius, A. J., Kaltenis, P. A., Baukiené, D. K.: Intestinal microflora during long-term use of cycloserine (in Russian). In: Problems of Infectious Pathology in Lithuanian SSR. Abstr. of Conference. Vilnius 1984, p. 112.
Welch, H., Putnam, L. E., Randall, W. A.: Antibactreial activity and blood and urine concentrations of cycloserine, a new antibiotic, following oral administration.Antibiot. Med., 1, 72 (1955).
Wise, R., Andrews, J. M.: In vitro activity of fludalanine combined with pentizidone compared with those of other agents.Antimicrob. Agents Chemother., 25, 612 (1984).
Zitkova, L., Toušek, J.: Pharmacokinetics of cycloserine and terizidone.Chemotherapy, 20, 18 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaltenis, P. Cycloserine as a urinary tract antiseptic. International Urology and Nephrology 18, 125–130 (1986). https://doi.org/10.1007/BF02082597
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02082597